Skip to main content

Published locations for Rosiglitazone May Curb Ulcerative Colitis Activity : In a study of 105 patients, 44% of those taking Avandia had clinical remission, vs. 23% on placebo.

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Rosiglitazone May Curb Ulcerative Colitis Activity : In a study of 105 patients, 44% of those taking Avandia had clinical remission, vs. 23% on placebo.

User login

  • Reset your password
  • /content/rosiglitazone-may-curb-ulcerative-colitis-activity-study-105-patients-44-those-taking
  • /internalmedicinenews/article/15213/gastroenterology/rosiglitazone-may-curb-ulcerative-colitis
  • /internalmedicine/article/15213/gastroenterology/rosiglitazone-may-curb-ulcerative-colitis-activity